Zoetis (ZTS) Non Operating Income (2012 - 2026)
Zoetis (ZTS) posted quarterly Non Operating Income of $20.0 million for Q1 2026, up 33.33% year-over-year from $15.0 million in Q1 2025, and up 122.22% quarter-over-quarter from $9.0 million in Q4 2025.
Zoetis (ZTS) Non Operating Income (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Non Operating Income for 15 consecutive years, with $20.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 33.33% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $38.0 million (up 46.15% YoY), while the FY2025 annual figure was $36.0 million, up 89.47% from the prior year.
- Non Operating Income improved to $20.0 million in Q1 2026 per ZTS's latest filing, from $9.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $104.0 million in Q2 2023 and bottomed at -$34.0 million in Q4 2022.
- Historically, Non Operating Income has averaged $11.2 million across 5 years, with a median of $8.0 million in 2023.
- On a YoY basis, Non Operating Income climbed as much as 5300.0% in 2023 and fell as far as 300.0% in 2023.
- Zoetis' Non Operating Income stood at -$34.0 million in 2022, then jumped by 123.53% to $8.0 million in 2023, then soared by 150.0% to $20.0 million in 2024, then sank by 55.0% to $9.0 million in 2025, then soared by 122.22% to $20.0 million in 2026.
- Business Quant data shows ZTS's Non Operating Income at $20.0 million in Q1 2026, $9.0 million in Q4 2025, and $13.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | -20.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 20.00 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | -25.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Sep 30, 2023 | -6.00 Mn |
| Jun 30, 2023 | 104.00 Mn |
| Mar 31, 2023 | 53.00 Mn |
| Dec 31, 2022 | -34.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | -2.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Dec 31, 2021 | -32.00 Mn |
| Sep 30, 2021 | -4.00 Mn |